Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generic drugs
Pharma
Teva CEO celebrates progress in 'Pivot to Growth' plan
While Teva still has a "long way to go," the company is executing well on its Pivot to Growth strategy, CEO Richard Francis told Fierce.
Fraiser Kansteiner
May 8, 2024 3:02pm
Supreme Court rejects Vanda's Hetlioz patent revival appeal
Apr 22, 2024 3:49pm
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
Generics face 'knowledge gap' against brand loyalty: GlobalData
Apr 8, 2024 12:09pm
Apotex buys specialty drugmaker Searchlight in expansion move
Apr 3, 2024 12:41pm
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Mar 29, 2024 1:10pm